PATENT CLAIM ANALYSIS

Application Number: 15990542
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["435", "091100"]

Abstract:
Provided herein are compositions and methods for the treatment of retinal diseases. The compositions and methods include a therapeutic agent conjugated to a vitreous component binding moiety. The vitreous component binding moiety may be an aptamer or a small molecule that binds to a structural component of the vitreous humor (e.g., hyaluronic acid, collagen or vitronectin).

Claim (Index 29):
The method of  claim 24 , wherein said administering comprises administering a dose of said composition of at least 2 mg to said subject in a single intravitreal administration.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 93.0
- Lexical Diversity: 1.46512
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10926806', '14768701', '15274612', '12465051', '15639573']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5941123329118008
- 35 USC 102 Novelty (BERT): 0.5075310821753242
- Combined Prediction Score: 0.5854542078381532
- Mean Citation Score: 239.18448000000004
- Max Citation Score: 243.5884
- Similarity Product: 151.53706852140428

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test